Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
Emanuela Romano(Kettering University), James W. Young(Memorial Sloan Kettering Cancer Center)
Cited by 51
Related Papers
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
|Proceedings of the National Academy of Sciences|2015|581
The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
|Journal of Clinical Investigation|1992|270